Nanotechnology-mediated therapeutic strategies against synucleinopathies in neurodegenerative disease-Reference-Cited by-同舟云学术

Nanotechnology-mediated therapeutic strategies against synucleinopathies in neurodegenerative disease

Published:2021-03 Issue: Volume:31 Page:100673
ISSN:2211-3398
Container-title:Current Opinion in Chemical Engineering
language:en
Short-container-title:Current Opinion in Chemical Engineering

Author:

Schlichtmann Benjamin W^ORCID,Hepker Monica,Palanisamy Bharathi N,John Manohar,Anantharam Vellareddy,Kanthasamy Anumantha G^ORCID,Narasimhan Balaji,Mallapragada Surya K

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

General Energy

Reference50 articles.

1. Economic Burden and Future Impact of Parkinson's Disease - Final Report;Yang,2019

2. Small molecule-mediated stabilization of vesicle-associated helical α-synuclein inhibits pathogenic misfolding and aggregation;Fonseca-Ornelas;Nat Commun,2014

3. Blood-brain barrier permeability is regulated by lipid transport-dependent suppression of caveolae-mediated transcytosis;Andreone;Neuron,2017

4. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study;Archer;Lancet Digit Health,2019

5. Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from Lewy body synucleinopathies;Singer;Ann Neurol,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding alpha-synuclein aggregation propensity in animals and humans;Biochemistry and Biophysics Reports;2024-09

2. Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression;Biomolecules;2023-07-31

3. Trends in Drug Delivery Systems for Natural Bioactive Molecules to Treat Health Disorders: The Importance of Nano-Liposomes;Pharmaceutics;2022-12-15

4. Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies;Theranostics;2022